NCT02978612View on ClinicalTrials.gov

Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III

PHASE2CompletedINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2022

Study Completion Date

January 31, 2025

Conditions

Colon Cancer

Interventions

DRUG

Capecitabine

Capecitabine is a prodrug to 5-fluorouracil. It is used for adjuvant chemotherapy after surgery for colon cancer. The tablets are either 150 mg or 500 mg

Trial Locations (1)

Unknown

Oslo University Hospital, Oslo

All Listed Sponsors

lead

Oslo University Hospital

OTHER

NCT02978612 - Adjuvant Chemotherapy In Elderly With Colon Cancer Stage III | Biotech Hunter | Biotech Hunter